Discovery of new lead pyrimidines derivatives as potential cannabinoid CB1 receptor antagonistic through molecular modeling and pharmacophore approach

Author： Sharma Mukesh  

Publisher： Springer Publishing Company

ISSN： 1054-2523

Source： Medicinal Chemistry Research, Vol.23, Iss.5, 2014-05, pp. : 2287-2311

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 20, 2015-10 ,pp. : 4790-4805

John Wiley & Sons Inc

Access to resources Recommend Favorite

In vivo imaging of the cannabinoid CB1 receptor with positron emission tomography

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 6, 2015-06 ,pp. : 565-567

John Wiley & Sons Inc

Access to resources Recommend Favorite

The discovery of potential cyclin A/CDK2 inhibitors: a combination of 3D QSAR pharmacophore modeling, virtual screening, and molecular docking studies

By Ece Abdulilah   Sevin Fatma  

Medicinal Chemistry Research, Vol. 22, Iss. 12, 2013-12 ,pp. : 5832-5843

Springer Publishing Company

Access to resources Recommend Favorite

A2A–CB1 receptor interaction in corticostriatal terminals

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 4, 2015-02 ,pp. : 1074-1086

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cannabinoid CB1 receptors mediate the effects of dipyrone

By  

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (ELECTRONIC), Vol. 42, Iss. 3, 2015-03 ,pp. : 246-255

John Wiley & Sons Inc

Access to resources Recommend Favorite